DENTSPLY SIRONA (XRAY) Receives Media Sentiment Rating of 0.10

Headlines about DENTSPLY SIRONA (NASDAQ:XRAY) have been trending somewhat positive recently, Accern reports. The research group rates the sentiment of press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. DENTSPLY SIRONA earned a news impact score of 0.10 on Accern’s scale. Accern also assigned news articles about the medical instruments supplier an impact score of 47.7924028627858 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Here are some of the news articles that may have effected Accern’s rankings:

XRAY has been the topic of several research reports. HC Wainwright reaffirmed a “buy” rating and issued a $68.00 price target (down previously from $74.00) on shares of DENTSPLY SIRONA in a report on Monday, August 14th. TheStreet cut DENTSPLY SIRONA from a “b” rating to a “c+” rating in a report on Wednesday, August 9th. Morgan Stanley upped their price target on DENTSPLY SIRONA from $66.00 to $67.00 and gave the company an “overweight” rating in a report on Thursday, August 10th. Zacks Investment Research raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price target on the stock in a report on Thursday, July 13th. Finally, Stifel Nicolaus reaffirmed a “buy” rating on shares of DENTSPLY SIRONA in a report on Thursday, October 19th. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $65.60.

Shares of DENTSPLY SIRONA (XRAY) traded up $3.64 during trading hours on Friday, reaching $64.80. 4,670,000 shares of the company’s stock traded hands, compared to its average volume of 2,110,000. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.55 and a current ratio of 2.34. DENTSPLY SIRONA has a 52 week low of $52.53 and a 52 week high of $66.00. The firm has a market cap of $14.87 billion, a P/E ratio of 24.76, a P/E/G ratio of 2.51 and a beta of 1.27.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.04. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $978.99 million. During the same period in the previous year, the business earned $0.66 EPS. The company’s revenue was up 5.8% on a year-over-year basis. analysts expect that DENTSPLY SIRONA will post 2.67 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This story was posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.com-unik.info/2017/11/04/dentsply-sirona-xray-receives-media-sentiment-rating-of-0-10.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Insider Buying and Selling by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

What are top analysts saying about DENTSPLY SIRONA Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for DENTSPLY SIRONA Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit